A user's review of commercial sample size software for design of biomedical studies using survival data

Controlled Clinical Trials

Volumn 18, Issue 1, 1997, Pages 65-83

  Iwane, Marika ^a   Palensky, Jolie ^a   Plante, Kathryn ^a  

^a University of Iowa   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; COMPUTER PROGRAM; STATISTICS;

CLINICAL TRIALS; DATA INTERPRETATION, STATISTICAL; HUMANS; RESEARCH DESIGN; SAMPLE SIZE; SOFTWARE; SURVIVAL ANALYSIS;

EID: 0031079833     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(96)00139-0     Document Type: Article

References (18)

1. 1. Frick H, Jauch S, Rahlfs VW. Nsurv. Version 2.2. Munich, Germany: idv-Institute für Datenanalyse und Versuchsplanung; 1994.
2. 2. Piantadosi S. Clinical Trials Design Program. Version 1. Ferguson, MO: Biosoft; 1990.
3. 3. EGRET SIZ. Version 1.0 Seattle, WA: Statistics and Epidemiology Research Corporation; 1993.
4. 4. Dupont WD, Plummer WD. Power and sample size calculations: a review and computer program. Controlled Clin Trials 1990;11:116-128.
5. 5. Hintze JL. Power Analysis and Sample Size. Version 1.0. Kaysville, UT: Number Cruncher Statistical System; 1993.
6. 6. Brent EE, Mirielli E, Thompson A. Ex-Sample™. Version 3.0. Columbia, MO: Idea Works, Inc.; 1993.
7. 7. Frick H. On Lachin's formulae for sample sizes of survival tests. Communications in Statistics-Theory Methodology 1991;20:2267-2280.
8. 8. Lachin JM, Foulkes MA. Evaluation of sample size and power for analysis of survival and allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification. Biometrics 1986;42:507-519.
9. 9. Rubinstein L, Gail M, Santner T. Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observation. J Chronic Disease 1981;34:469-479.
10. 10. Freedman, L. Tables of the number of patients required in clinical trials using the logrank test. Stat in Med 1982;1:121-129.
11. 11. Zelen M, Dannemiller M. The robustness of life testing procedures derived from the exponential distribution. Technometrics 1961;3:29-49.
12. 12. Self S, Mauritsen R, Ohara J. Power calculations of likelihood ratio tests in generalized linear models. Biometrics 1992;48:31-39.
13. 13. Schoenfeld D, Richter J. Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint. Biometrics 1982;38:163-170.
14. 14. Hsieh F. SSIZE: A Sample Size Program for Clinical and Epidemiological Studies. Palo Alto, CA: Department of Veterans Affairs Cooperative Studies Program Coordinating Center; 1991.
15. 15. Shuster J. Handbook of Sample Size Guidelines for Clinical Trials. West Palm Beach, FL: CRC Press, Inc.; 1990.
16. 16. Schoenfeld D. The asymptotic properties of nonparametric tests for comparing survival distributions. Biometrika 1981;68:316-319.
17. 17. Lakatos E. Sample size determination in clinical trials with time-dependent rates of losses and noncompliance. Controlled Clin Trials 1986;7:189-199.
18. 18. Shih J. Sample size calculation for complex clinical trials with survival endpoints. Controlled Clin Trials 1995;16:395-407.